DQWS · XBRL financial data

DSwiss financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (DQWS's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	2	—	3	1	2	—	—	—	—	—	—	—
Revenue from contracts with customers	426	423*	471	579	1,027	1,035*	1,001	1,021	442	457*	478	512
Cost of revenue	281	382*	201	447	914	927*	738	873	383	363*	319	342
Gross profit	145	—	270	132	113	—	263	149	59	—	159	169
Selling, general and administrative	89	97*	94	110	166	234*	119	135	140	235*	142	168
General and administrative	2	—	2	4	2	—	—	—	—	—	—	—
Other operating income (expense)	1	2*	2	4	3	4*	1	31	1	6*	1	9
Operating income (loss)	(0)	(0)*	(0)	(0)	(0)	(0)*	—	(1)	(0)	(0)*	(0)	(0)
Income tax expense (benefit)	0	0*	0	4	11	(8)*	2	2	7	5*	3	3
Net income (loss)	45	(66)*	178	21	(61)	(115)*	139	32	(98)	(150)*	4	(3)
Earnings per share, basic USD per share	0.00	0.00*	0.00	0.00	(0.00)	0.00*	0.00	0.00	(0.00)	0.00*	0.00	(0.00)
Earnings per share, diluted USD per share	0.00	0.00*	0.00	0.00	(0.00)	0.00*	0.00	0.00	(0.00)	0.00*	0.00	(0.00)
Weighted average shares, basic thousands of shares	206,905	206,905*	206,905	206,905	206,905	206,905*	206,905	206,905	206,905	206,905*	206,905	206,905
Weighted average shares, diluted thousands of shares	206,905	206,905*	206,905	206,905	206,905	206,905*	206,905	206,905	206,905	206,905*	206,905	206,905

Fiscal quarters (DQWS's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	289	249	305	458	473	397	305	581	368	285	220	258
Accounts receivable	37	36	62	38	51	75	63	55	38	17	75	19
Inventory	8	7	6	5	5	3	3	4	4	2	2	2
Prepaid and other current assets	19	25	24	28	243	22	193	19	40	27	64	55
Total current assets	354	317	397	530	772	498	564	660	450	332	362	334
Property and equipment, net	51	48	43	40	43	137	131	129	194	189	176	161
Right-of-use asset	11	—	—	—	—	—	159	162	156	156	150	142
Total assets	418	367	442	571	817	636	855	952	801	677	688	637
Accounts payable	103	99	37	87	284	153	222	201	148	113	204	103
Total current liabilities	287	295	192	309	601	484	421	469	413	465	472	425
Lease liability, non-current	—	—	—	—	—	—	135	142	142	129	130	129
Total liabilities	323	311	207	325	618	562	642	702	652	686	693	645
Accumulated deficit	(1,345)	(1,410)	(1,232)	(1,211)	(1,273)	(1,388)	(1,249)	(1,217)	(1,315)	(1,465)	(1,460)	(1,463)
Total stockholders' equity	95	56	235	247	199	74	213	250	149	(9)	(6)	(8)
Total liabilities and equity	418	367	442	571	817	636	855	952	801	677	688	637
Common shares outstanding (cover page) thousands of shares	206,905	206,905	206,905	206,905	206,905	206,905	206,905	206,905	206,905	206,905	206,905	206,905

Fiscal quarters (DQWS's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	45	(66)*	178	21	(61)	(115)*	139	32	(98)	(150)*	4	(3)
Depreciation and amortization	15*	14*	3	3*	4*	—	—	—	—	—	—	—
Net cash from operating activities	183*	(66)*	63	167*	(12)*	(35)*	(85)	233*	(167)*	(76)*	(55)	50*
Purchases of property and equipment	—	0*	—	—	—	104*	1	1*	36*	3*	0	0*
Net cash from investing activities	—	(0)*	0	0*	(2)*	(104)*	(1)	30*	(36)*	(2)*	(0)	(0)*
Net cash from financing activities	(4)*	(4)*	(4)	(4)*	(6)*	82*	(8)	(9)*	(8)*	(10)*	(9)	(9)*
Net change in cash	175*	(40)*	56	153*	15*	(76)*	(93)	276*	(213)*	(82)*	(65)	38*

SIC 2844 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2844 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
DSwiss	258	512	50*	206.9M	—	Q2 FY26 10-QJun 30, 2026
Longevity Health Holdings	35	396	(224)*	2.5M	0.2 quarters	Q2 FY26 10-QJun 30, 2026
Karbon-X	335	344	(1,198)	109.2M	—	Q1 FY27 10-Q/AAug 31, 2026
Bonk	214	793	(2,226)*	8.0M	0.1 quarters	Q2 FY26 10-QJun 30, 2026
Scientist Home Future Health	14	212	(45)*	23.7M	—	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.